In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jago Holding AG

Division of Vectura Group PLC

Latest From Jago Holding AG

Somatogen's Pot O' Gold

For Somatogen and many others, the earnout potential in M&As not only extends the time frame they need to achieve certain milestones and/or sales goals, but allows them to receive higher purchase prices.
BioPharmaceutical

Biotech Models, Part I: Near-Term Strategies

As biotech valuations turn south, VCs are searching for financeable models for new companies. In Part I of a two-part article, we examine near-term models. The message: Choose distribution or research, but not both at the same time.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Vectura Group PLC
  • Senior Management
  • Jacques Gonella, PhD, CEO
    Peter F Burrell, CFO
    Andy Francis, VP, Bus. Dev.
    Robert Zimmer, MD, VP, R&D
  • Contact Info
  • Jago Holding AG
    Phone: (41) 441 614675555
    Eptingerstrasse 51
    Muttenz/Basel, CH-4132
    Switzerland
UsernamePublicRestriction

Register